glp 1 agonists mechanism of action Glucagon-like peptide-1 Mechanisms of GLP-1 Receptor Agonist-Induced

Impact of Glucagon-Like Peptide-1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population-Based Longitudinal Cohort Study

Vivier E, Rebuffet L, Narni-Mancinelli E, Cornen S, Igarashi RY, Fantin VR

Its important to understand that most side effects are usually mild to moderate

TNF- is found at high levels in the synovium of patients with RA [234], while IL-1 is recognized as a major contributor to inflammation in the disease [235]

The numerous beneficial effects of GLP-1 render this hormone an interesting candidate for the development of pharmacotherapies to treat obesity, diabetes, and neurodegenerative disorders Keywords: GLP-1, Insulin, Glucagon, Diabetes, Obesity, Incretin 1

Aitman, T